News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
SubhenduBasu_ceo
Telum Therapeutics appoints Dr. Subhendu Basu as CEO
Communication
Subhendu Basu replaces Roberto Diez-Martinez in the position, who becomes Chief Operating Officer.
Premiados Batx2Lab
Barcelona Science Park awards prizes for 20th BATX2LAB programme
Talento
The Barcelona Science Park awarded the prizes for the 20th BATX2LAB, an initiative within the PCB…
Laboratorio_Biotecnología_AseBio
Mahana Therapeutics acquires Cara Care (Asabys) to become a global platform for digital therapies for the digestive system and other chronic diseases
Healthcare · Financing · Corporate
The combination creates a global company that offers the most comprehensive digestive health…
Carles Domènech horitzontal
AbilityPharma closes €7 million round for metastatic pancreatic cancer drug ABTL0812
Healthcare · Rare diseases · Advanced therapies · Financing
AbilityPharma closes €7 million round to fully fund its international Phase 2b clinical trial with…
BCN HEALTH publica un estudio sobre los pacientes con atrofia muscular espinal
Patient-Centric Design in the Development of Healthcare Solutions
Healthcare
How can Life Sciences companies ensure that the solutions they spend years developing truly respond…
a
Where to find BIAT GROUP in March 2024 🔎
Healthcare · Climate change · Agrifood · Gene editing · International · Communication · Corporate
2024 Smart Agrifood Summit;   TRANSFIERE 2024, 3rd European Meeting on Science, Technology…
a
Where to find Biobide in March 2024 🔎
Healthcare · Climate change · Agrifood · Circular economy · Communication · Corporate
Meet our team at the 2024 Society of Toxicology (SOT) Annual Meeting and ToxExpo We will…
TransMisione
Spanish researchers to design proteins using AI to make advanced therapies more efficient
Healthcare · Rare diseases · Financing
The project will be undertaken by a public-private consortium formed by VIVEbiotech, Integra…
OneChain team
OneChain Immunotherapeutics has received 1.3M euro grant to advance a new promising CAR T therapy for a rare leukemia
Healthcare · Rare diseases · Advanced therapies
A consortium led by the Spanish company OneChain Immunotherapeutics has received 1.9M euros from…